Clinical trial
Neurodevelopmental Outcome of Early Dietary Lysine Restriction in Pyridoxine
NCT01795170 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neurodevelopmental Outcome of Early Dietary Lysine Restriction in Pyridoxine
- Lead sponsor
- University of British Columbia
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- April 30, 2013
- Completion date
- November 30, 2016
- Enrollment
- 0 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
pyridoxine dependant epilepsy